News

A new study showcases the potential of artificial intelligence (AI) for analyzing brain images during stroke. The process of lesion segmentation normally involves manual analysis by expert radiologists, but new techniques could speed up the analysis.

Recent work has found that people at times prefer less information, even when this means they might not be able to make fully informed decisions. However, little is known about the prevalence of such avoidance. Who are the people who choose blissful ignorance over facing reality?

Physician burnout is a significantly underappreciated public safety issue, and sleep loss is often overlooked as a contributing factor, according to a new position statement published by the American Academy of Sleep Medicine.

A first-of-its-kind trial has demonstrated that a receptor involved in the brain’s reward system may be a viable target for treating anhedonia (or lack of pleasure), a key symptom of several mood and anxiety disorders. This innovative fast-fail trial was funded by the National Institute of Mental Health (NIMH), part of the National Institutes of Health, and the results of the trial are published in Nature Medicine.

There has been a lot of recent interest in the use of psychedelic drugs to treat depression. A new study suggests that, in the right context, some people may experience psychedelic-like effects from placebos alone.

Using a newly developed laboratory model of three types of brain cells, Penn and CHOP scientists reveal how HIV infection—as well as the drugs that treat it—can take a toll on the central nervous system.

Researchers at the National Institutes of Health have discovered in mice what they believe is the first known genetic mutation to improve cognitive flexibility—the ability to adapt to changing situations.

Women who suffer from psychiatric disorders such as depression, anxiety, mania and schizophrenia following the live birth of their first child are less likely to go on to have more children, according to the first study to investigate this in a large nationwide population.

Researchers at Karolinska Institutet and St Erik Eye Hospital in Sweden have discovered a way to refine the production of retinal cells from embryonic stem cells for treating blindness in the elderly.

Technique may enable speedy, on-demand design of softer, safer neural devices.